Phil Tracy joined Intersouth in 1997. His pharmaceutical background provides Intersouth with extensive experience in the healthcare industry. He serves on the boards of directors of two Intersouth portfolio companies and has served as interim CEO of an Intersouth portfolio company.
The majority of Phil's career was spent at Burroughs Wellcome Co., a major research-based pharmaceutical company with $1.2 billion in sales and 5,000 employees. At Burroughs Wellcome, he served as President and CEO from 1989 until the company's merger with Glaxo in 1995.
Phil has served on the boards of directors of the Pharmaceutical Research and Manufacturers Association of America and the Nonprescription Drug Manufacturers Association. He has also served as chairman of the board of visitors for the Duke University Medical Center and as a member of the board of visitors for the University of North Carolina at Chapel Hill.
Phil currently serves on the boards of directors of the Burroughs Wellcome Fund and Peace College. He received a B.A. from the University of Nebraska and a J.D. and L.L.B. from George Washington University.